KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Asset Writedowns and Impairment (2016 - 2025)

Tenet Healthcare's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $64.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 137.04% year-over-year to $64.0 million; the TTM value through Dec 2025 reached $130.0 million, up 27.45%, while the annual FY2025 figure was $130.0 million, 27.45% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $64.0 million at Tenet Healthcare, up from $23.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $129.0 million in Q4 2022 and bottomed at $15.0 million in Q3 2021.
  • The 5-year median for Asset Writedowns and Impairment is $24.0 million (2022), against an average of $34.0 million.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 75.81% in 2021 before it skyrocketed 330.0% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $30.0 million in 2021, then surged by 330.0% to $129.0 million in 2022, then tumbled by 58.91% to $53.0 million in 2023, then plummeted by 49.06% to $27.0 million in 2024, then surged by 137.04% to $64.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Asset Writedowns and Impairment are $64.0 million (Q4 2025), $23.0 million (Q3 2025), and $24.0 million (Q2 2025).